The Joint Corp. (JYNT)
NASDAQ: JYNT · IEX Real-Time Price · USD
12.18
+0.26 (2.18%)
At close: Apr 19, 2024, 4:00 PM
12.35
+0.17 (1.40%)
After-hours: Apr 19, 2024, 5:07 PM EDT

Company Description

The Joint Corp. operates and franchises chiropractic clinics in the United States.

The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

The Joint Corp.
The Joint logo
Country United States
Founded 2010
IPO Date Nov 11, 2014
Industry Medical Care Facilities
Sector Healthcare
Employees 444
CEO Peter D. Holt

Contact Details

Address:
16767 N Perimeter Drive, Suite 110
Scottsdale, Arizona 85260
United States
Phone 480 245 5960
Website thejoint.com

Stock Details

Ticker Symbol JYNT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001612630
CUSIP Number 47973J102
ISIN Number US47973J1025
Employer ID 90-0544160
SIC Code 6794

Key Executives

Name Position
Peter D. Holt Chief Executive Officer, President and Director
Jake Singleton Chief Financial Officer
Jorge Armenteros Senior Vice President of Operations
Charles Nelles Chief Technology Officer
Dr. Steven Knauf Vice President of Chiropractic and Compliance
Lori I. Abou Habib Chief Marketing Officer
Krischelle Tennessen Chief Human Resources Officer
Eric Simon Senior Vice President of Franchise Sales and Development
Craig P. Colmar J.D. Secretary

Latest SEC Filings

Date Type Title
Apr 19, 2024 DEF 14A Other definitive proxy statements
Mar 8, 2024 10-K Annual Report
Mar 7, 2024 8-K Current Report
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 26, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 13, 2023 10-Q Quarterly Report
Nov 9, 2023 8-K Current Report
Nov 8, 2023 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Nov 8, 2023 8-K Current Report